The Latest Breaking News from Merck

The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments

Pharma has a "choice": Negotiate with HHS or pay $10 million "tax" per day.

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion

The lawsuit argues that the negotiation program violates the Fifth Amendment by not paying the company “just compensation” for its products.

Merck sued the Biden administration Tuesday, saying a drug-pricing law is a "sham." The legal battle will impact pharmaceutical stocks.

Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers. Here's where things stand.

Merck say “30-plus” jobs are expected to add to an existing workforce of 99.

The expansion plan should create nearly 500 new jobs in Glasgow and Stirling

During times of uncertainty, an investor can use a covered call to deliver downside protection while capturing upside gains. Here’s how it works.

While effective vaccines for COVID-19 should have heralded the benefits of mRNA vaccines, fear and misinformation about their supposed dangers circulated at the same time. These misconceptions about mRNA vaccines have recently spilled over into worries about whether their use in agricultural animals could expose people to components of the…

A trader selling the July 21, 115-strike put could generate around $300 in premium per contract.